These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 8632403)

  • 1. Bis(31/31') ([CYS(31), Trp(32), Nva(34)] NPY-(31-36)): a specific NPY Y-1 receptor antagonist.
    Balasubramaniam A; Zhai W; Sheriff S; Tao Z; Chance WT; Fischer JE; Eden P; Taylor J
    J Med Chem; 1996 Feb; 39(4):811-3. PubMed ID: 8632403
    [No Abstract]   [Full Text] [Related]  

  • 2. The novel neuropeptide Y Y(1) receptor antagonist J-104870: a potent feeding suppressant with oral bioavailability.
    Kanatani A; Kanno T; Ishihara A; Hata M; Sakuraba A; Tanaka T; Tsuchiya Y; Mase T; Fukuroda T; Fukami T; Ihara M
    Biochem Biophys Res Commun; 1999 Dec; 266(1):88-91. PubMed ID: 10581170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antagonistic properties of centrally truncated analogs of [D-Trp(32)]NPY.
    Balasubramaniam A; Ujhelyi M; Borchers M; Huang Y; Zhai W; Zhou Y; Johnson M; Sheriff S; Fischer JE
    J Med Chem; 1996 Mar; 39(5):1142-7. PubMed ID: 8676351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of neuropeptide Y-induced feeding in mice: do Y1-Y6 receptor subtypes mediate feeding?
    Iyengar S; Li DL; Simmons RM
    J Pharmacol Exp Ther; 1999 May; 289(2):1031-40. PubMed ID: 10215684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of chimeric NPY/galanin peptides M32 and M242 to cloned neuropeptide Y receptor subtypes Y1, Y2, Y4, and Y5.
    Berglund MM; Saar K; Lundell I; Langel U; Larhammar D
    Neuropeptides; 2001; 35(3-4):148-53. PubMed ID: 11884204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity analysis of N-acetyl [Leu(28,31)] NPY 24-36: a potent neuropeptide Y Y(2) receptor agonist.
    Smith-White MA; Potter EK
    Neuropeptides; 1999 Dec; 33(6):526-33. PubMed ID: 10657536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of hypothalamic neuropeptide Y in feeding and obesity.
    Gehlert DR
    Neuropeptides; 1999 Oct; 33(5):329-38. PubMed ID: 10657510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulation of neuropeptide Y levels and modulation of glutamate release through neuropeptide Y receptors in the hippocampus of kainate-induced epileptic rats.
    Silva AP; Xapelli S; Pinheiro PS; Ferreira R; Lourenço J; Cristóvão A; Grouzmann E; Cavadas C; Oliveira CR; Malva JO
    J Neurochem; 2005 Apr; 93(1):163-70. PubMed ID: 15773916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for involvement of neuropeptide Y receptors in the regulation of food intake: studies with Y1-selective antagonist BIBP3226.
    Kask A; Rägo L; Harro J
    Br J Pharmacol; 1998 Aug; 124(7):1507-15. PubMed ID: 9723965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of robust functional assays for the characterization of neuropeptide Y (NPY) receptors: identification of 3-(5-benzoyl-thiazol-2-ylamino)-benzonitrile as selective NPY type 5 receptor antagonist.
    Dautzenberg FM; Higelin J; Pflieger P; Neidhart W; Guba W
    Neuropharmacology; 2005 Jun; 48(7):1043-55. PubMed ID: 15857631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of G proteins by neuropeptide Y and gamma-aminobutyric acid(B) receptor agonists in rat cerebral cortical membranes through distinct modes of action.
    Odagaki Y; Nishi N; Nakagawa S; Koyama T
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1250-6. PubMed ID: 10565849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NMDA receptors mediate feeding elicited by neuropeptide Y in the lateral and perifornical hypothalamus.
    Lee SW; Stanley BG
    Brain Res; 2005 Nov; 1063(1):1-8. PubMed ID: 16259968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bis(31/31')[[Cys(31), Nva(34)]NPY(27-36)-NH(2)]: a neuropeptide Y (NPY) Y(5) receptor selective agonist with a latent stimulatory effect on food intake in rats.
    Balasubramaniam A; Sheriff S; Zhai W; Chance WT
    Peptides; 2002 Aug; 23(8):1485-90. PubMed ID: 12182951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropeptide Y and the nonpeptide antagonist BIBP 3226 share an overlapping binding site at the human Y1 receptor.
    Sautel M; Rudolf K; Wittneben H; Herzog H; Martinez R; Munoz M; Eberlein W; Engel W; Walker P; Beck-Sickinger AG
    Mol Pharmacol; 1996 Aug; 50(2):285-92. PubMed ID: 8700135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel range based QSAR study of human neuropeptide Y (NPY) Y5 receptor inhibitors.
    Deswal S; Roy N
    Eur J Med Chem; 2007 Apr; 42(4):463-70. PubMed ID: 17083999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of covalent dimerization on the structure and function of the carboxy-terminal fragment of neuropeptide Y.
    Uegaki K; Murase S; Nemoto N; Kobayashi Y; Yoshikawa S; Yumoto N
    Biochem Biophys Res Commun; 1997 Dec; 241(3):737-43. PubMed ID: 9434778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropeptide Y modulates the antidepressant activity of imipramine in olfactory bulbectomized rats: involvement of NPY Y1 receptors.
    Goyal SN; Upadhya MA; Kokare DM; Bhisikar SM; Subhedar NK
    Brain Res; 2009 Apr; 1266():45-53. PubMed ID: 19254701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergism between neuropeptide Y and norepinephrine highlights sympathetic cotransmission: studies in rat arterial mesenteric bed with neuropeptide Y, analogs, and BIBP 3226.
    Cortés V; Donoso MV; Brown N; Fanjul R; López C; Fournier A; Huidobro-Toro JP
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1313-22. PubMed ID: 10336522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropeptide Y regulates recurrent mossy fiber synaptic transmission less effectively in mice than in rats: Correlation with Y2 receptor plasticity.
    Tu B; Jiao Y; Herzog H; Nadler JV
    Neuroscience; 2006 Dec; 143(4):1085-94. PubMed ID: 17027162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of new hydrazide derivatives as neuropeptide Y Y5 receptor antagonists for the treatment of obesity.
    Juanenea L; Galiano S; Erviti O; Moreno A; Pérez S; Aldana I; Monge A
    Bioorg Med Chem; 2004 Sep; 12(17):4717-23. PubMed ID: 15358298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.